No black box warning on record for Sodium Sulfacetamide

As of the latest FDA labeling reviewed, Sodium Sulfacetamide (SODIUM SULFACETAMIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sodium Sulfacetamide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF

No black box warning on record for Sodium Sulfacetamide

Other warnings & precautions

WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF

Sodium Sulfacetamide Black Box Warning

No black box warning on record for Sodium Sulfacetamide

Other warnings & precautions

Sodium Sulfacetamide Black Box Warning

No black box warning on record for Sodium Sulfacetamide

Other warnings & precautions